| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1049283115 |
| P356 | DOI | 10.1023/A:1022207917249 |
| P698 | PubMed publication ID | 12716035 |
| P50 | author | Gregory P. Kalemkerian | Q124968136 |
| Shirish M Gadgeel | Q124968314 | ||
| P433 | issue | 1 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 39-46 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Cancer and Metastasis Reviews | Q2647982 |
| P1476 | title | Racial differences in lung cancer. | |
| P478 | volume | 22 |
| Q36456183 | African Americans' responses to genetic explanations of lung cancer disparities and their willingness to participate in clinical genetics research |
| Q34978347 | Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients |
| Q24622261 | Biomarkers of Psychological Stress in Health Disparities Research |
| Q38714278 | Cigarette-Smoking Trajectories of Monoracial and Biracial Blacks: Testing the Intermediate Hypothesis |
| Q39843433 | Clinical Characteristics and Presentation of Lung Cancer According to Race and Place of Birth |
| Q92846367 | College affirmative action bans and smoking and alcohol use among underrepresented minority adolescents in the United States: A difference-in-differences study |
| Q36951322 | Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer |
| Q37406138 | Cost disparities in lung cancer treatment by disability status, sex, and race |
| Q33788556 | Development and validation of a lung cancer risk prediction model for African-Americans |
| Q35354379 | Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks |
| Q36054884 | Enhancing life after cancer in diverse communities |
| Q36607842 | Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1 |
| Q37432088 | Five-Year Cancer Survival Rates in Oklahoma from 1997 to 2008. |
| Q36883416 | Gender, Ethnicity, and Their Intersectionality in the Prediction of Smoking Outcome Expectancies in Regular Cigarette Smokers |
| Q49841145 | Histologic Lung Cancer Incidence Rates and Trends vary by Race/Ethnicity and Residential County. |
| Q51804779 | Lung cancer death rates in lifelong nonsmokers. |
| Q37208485 | Mapping cancer mortality-to-incidence ratios to illustrate racial and sex disparities in a high-risk population |
| Q37171105 | Mentholated cigarettes and smoking-related cancers revisited: an ecologic examination |
| Q37080029 | Obesity in relation to lung cancer incidence in African American women |
| Q35197230 | Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer. |
| Q83182457 | PARP1 polymorphisms increase the risk of gastric cancer in a Chinese population |
| Q35345710 | Perspectives of African Americans on lung cancer: a qualitative analysis |
| Q27968997 | Post-9/11/2001 lung function trajectories by sex and race in World Trade Center-exposed New York City emergency medical service workers |
| Q40993022 | Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. |
| Q37296979 | Racial and Gender Disparities in Incidence of Lung and Bronchus Cancer in the United States: A Longitudinal Analysis |
| Q45418116 | Racial and regional disparities in lung cancer incidence |
| Q45279303 | Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). |
| Q33790312 | Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey |
| Q57272317 | Racial disparities in stage-specific colorectal cancer mortality: 1960-2005 |
| Q35342011 | Racial/ethnic differences in use of alcohol, tobacco, and marijuana: is there a cross-over from adolescence to adulthood? |
| Q39063441 | Residential Segregation and Racial Cancer Disparities: A Systematic Review |
| Q33648093 | Smoking behavior and lung cancer in a biracial cohort: the Atherosclerosis Risk in Communities study. |
| Q87259111 | Socioeconomic status and lung cancer: unraveling the contribution of genetic admixture |
| Q37293737 | Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States |
| Q90468831 | The association of neighborhood-level social class and tobacco consumption with adverse lung cancer characteristics in Maryland |
| Q51465617 | The cigar ambassador: how Snoop Dogg uses Instagram to promote tobacco use. |
| Q37136654 | The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy |
| Q49307254 | Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity |
| Q36852163 | Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer |
| Q36103367 | Who is at high risk for lung cancer? Population-level and individual-level perspectives |
| Q36000921 | YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells. |
Search more.